Related Experiment Video
Updated: Jul 6, 2025

06:26
Pre-clinical Model of Cardiac Donation after Circulatory Death
Published on: August 2, 2019
8.0K
[Postmortem genetic analysis following sudden cardiac death : Background, approach, and future]
Silke Kauferstein1,2, Britt-Maria Beckmann3
1Institut für Rechtsmedizin, Zentrum für plötzlichen Herztod und familiäre Arrhythmiesyndrome, Universitätsklinikum Frankfurt, Kennedyallee 104, 60590, Frankfurt, Deutschland. kauferstein@em.uni-frankfurt.de.
Herzschrittmachertherapie & Elektrophysiologie
|January 10, 2024
Summary
Postmortem genetic analysis, or molecular autopsy, identifies inheritable causes of sudden cardiac death (SCD) in young individuals. This genetic testing is crucial for diagnosing the cause of death and preventing SCD in at-risk relatives.
Area of Science:
- Cardiovascular Genetics
- Molecular Autopsy
- Sudden Cardiac Death (SCD) Etiology
Context:
- Sudden cardiac death (SCD) has varying incidence across age groups, with monogenetic and polygenetic diseases predominating in younger individuals.
- Coronary artery disease is a common cause of SCD in older populations.
- Molecular autopsy is increasingly vital for investigating unexplained SCD.
Purpose:
- To highlight the significance of postmortem genetic analysis in identifying the causes of sudden cardiac death in young patients.
- To emphasize the role of next-generation sequencing in detecting pathogenic genetic alterations.
- To underscore the importance of genetic testing for the early identification and prevention of SCD in at-risk relatives.
Summary:
- Postmortem genetic analysis, utilizing next-generation sequencing, can identify pathogenic genetic alterations in approximately 20% of young sudden cardiac death cases.
- This molecular autopsy approach is essential for unraveling inheritable causes of death.
- Early identification of genetic variants in deceased individuals enables preventive measures for at-risk family members.
Impact:
- Postmortem genetic analysis, combined with clinical assessment, facilitates the early identification of relatives at risk for inherited cardiac conditions.
- Recent European Society of Cardiology guidelines prioritize genetic testing, including in deceased individuals, for diagnosing, stratifying risk, and preventing sudden death.
- This approach enhances personalized medicine strategies for cardiovascular disease prevention.

